Bachem Holding AG

SWX:BANB Lagerbericht

Marktkapitalisierung: CHF 5.3b

Bachem Holding Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Bachem Holding wird ein jährliches Gewinn- und Umsatzwachstum von 15.8% bzw. 17% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 16.3% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 14.1% betragen.

Wichtige Informationen

15.8%

Wachstumsrate der Gewinne

16.27%

EPS-Wachstumsrate

Life Sciences Gewinnwachstum19.0%
Wachstumsrate der Einnahmen17.0%
Zukünftige Eigenkapitalrendite14.12%
Analystenabdeckung

Good

Zuletzt aktualisiert12 Jun 2026

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Narrativ-Update • Jun 22

BANB: Capacity Expansion Commitments Will Heighten Execution Risk And Restrain Upside

Analysts have raised their price target on Bachem Holding by CHF 5 to reflect updated assumptions for discount rates, growth and profitability. This move is supported by recent Street research that cites a higher target from CHF 5 at Barclays as a reference point for the new CHF level.
Narrativ-Update • Jun 05

BANB: Future Upside Will Rely On Executing Margin Assumptions And Higher P E Framework

Analysts have raised their CHF price targets on Bachem Holding, including recent CHF 5 and CHF 5 increases from two major banks, reflecting updated views on growth, margins, and future P/E assumptions. Analyst Commentary Bullish analysts are signaling a constructive view on Bachem Holding, pointing to updated price targets that reflect their latest assumptions on growth, margins, and valuation.
Narrativ-Update • May 22

BANB: Higher Assumed Growth Will Exacerbate Execution Risk And Limit Upside

Analysts have nudged their price targets for Bachem Holding higher, with recent Street research citing revised assumptions for growth, margins and P/E that collectively support a modestly higher fair value approach in CHF terms. Analyst Commentary Recent price target revisions for Bachem Holding sit in a fairly tight range, with updates clustered around the CHF 80 level.
Narrativ-Update • May 01

BANB: Future Earnings Execution Is Expected To Support CHF 80 Upside Potential

Analysts have nudged their price target on Bachem Holding slightly higher, with recent Street research indicating a CHF 5 increase from both Barclays and Deutsche Bank to CHF 80, supported by updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Bullish Takeaways Bullish analysts see the move to a CHF 80 target as aligned with their updated view on fair value, suggesting that current assumptions on growth and margins justify a higher valuation anchor.
Neues Narrativ • Apr 26

Bachem Holding - The Purest Public Peptide Play?

We are living through a biological revolution. You see it on the balance sheets of the world’s largest pharmaceutical companies and you see it in the cultural zeitgeist.
Narrativ-Update • Apr 16

BANB: Future Upside Will Depend On Executing Profit Margin Assumptions

Narrative Update Bachem Holding's updated analyst price target now reflects a modest recalibration in assumptions, with recent CHF 5, CHF 80, and CHF 32 target increases cited by analysts who point to slightly higher profit margin expectations and a small adjustment to the assumed P/E multiple as key drivers. Analyst Commentary Recent research updates on Bachem Holding have leaned constructive, with bullish analysts adjusting their price targets upward and citing a mix of valuation and execution factors.
Narrativ-Update • Apr 02

BANB: Future Execution On Project Pipeline Will Support CHF 80 Upside Potential

Narrative Update Analyst price targets for Bachem Holding have shifted to a range of CHF 60 to CHF 80, with the upper end raised from CHF 75, as analysts reflect updated views on the company in their valuation work. Analyst Commentary Recent research updates on Bachem Holding point to a split in how analysts see the risk and reward around the stock, which feeds directly into the current CHF 60 to CHF 80 price target range.
Narrativ-Update • Mar 19

BANB: Future Execution On Growth Plans Will Support Higher CHF 80 Upside Potential

Analysts have nudged the consolidated price target for Bachem Holding to CHF 80, up CHF 5 from prior levels, citing updated assumptions for growth, profitability and a slightly lower P/E outlook that align with recent Street research moves. Analyst Commentary Street research on Bachem Holding has been mixed, with some analysts lifting price targets toward CHF 80 while others are more hesitant and keep targets closer to CHF 60.
Narrativ-Update • Mar 05

BANB: Future Execution On Pipeline Plans Will Support Higher Market Confidence

The updated analyst price target for Bachem Holding suggests a modest upward revision to fair value to CHF 78.66, with analysts citing slightly adjusted assumptions for the discount rate, revenue growth, profit margins, and future P/E expectations. Analyst Commentary Bullish Takeaways Bullish analysts point to the higher price target as a signal that their assumptions for Bachem Holding’s future earnings and cash flows now support a fair value above the prior level, even after revisiting discount rate and P/E inputs.
Narrativ-Update • Feb 18

BANB: Future Pipeline Execution Will Drive Upside Versus Recent Cautious Views

Analysts have adjusted their fair value estimate for Bachem Holding to CHF 76.59, reflecting updated views on growth, profitability and valuation following recent price target revisions that include a CHF 32 increase from RBC Capital and a reduction to CHF 60 from Barclays. Analyst Commentary Recent research shows a split view on Bachem Holding, with some bullish analysts lifting targets and more cautious voices trimming expectations.
Narrativ-Update • Feb 04

BANB: Higher Fair Value Will Rely On Execution Of Existing Order Book

Analysts have raised their fair value estimate for Bachem Holding from CHF 100.00 to CHF 110.00, citing updated assumptions around revenue growth, profit margins and future P/E multiples that are in line with recent Street target changes, including the higher price target from RBC and the revised level from Barclays. Analyst Commentary Recent research updates around Bachem Holding give you a mixed but useful read on how the Street is thinking about valuation and execution.
Narrativ-Update • Jan 21

BANB: Building K Execution Risks Will Limit Future Share Upside

Analysts have nudged their price target on Bachem Holding slightly lower to about CHF 60 to CHF 75, reflecting updated assumptions around discount rates, revenue growth near 21.5% and an expected future P/E close to 18.9%. They are also weighing recent research that includes a reduced CHF 60 target alongside a CHF 75 target tied to the company’s Building K expansion plans.
Narrativ-Update • Jan 07

BANB: Building K Execution Risk Will Constrain Future Upside Potential

Analysts have trimmed their average price target on Bachem Holding to CHF 60 from CHF 75, citing updated assumptions for revenue growth, profit margins and future P/E multiples that reflect a more measured outlook, even as expansion projects remain in focus. Analyst Commentary Recent street research on Bachem highlights a mix of views, with some analysts seeing potential tied to expansion projects such as Building K, while others are recalibrating expectations and price targets to reflect what they view as a more balanced risk and reward profile.
Narrativ-Update • Dec 14

BANB Building K Expansion Will Define Future Upside And Execution Risk

Analysts have raised their price target for Bachem Holding from approximately CHF 58 to about CHF 75, citing increased confidence in revenue growth driven by the company's Building K expansion project, despite a slightly higher discount rate and modestly lower profit margin and valuation multiples. Analyst Commentary Recent research commentary highlights a more constructive stance on Bachem Holding, with the upgraded price target to CHF 75 framed around the growth potential from the Building K expansion project.
Analyseartikel • Dec 01

At CHF51.85, Is Bachem Holding AG (VTX:BANB) Worth Looking At Closely?

While Bachem Holding AG ( VTX:BANB ) might not have the largest market cap around , it received a lot of attention from...
Analyseartikel • Oct 25

Bachem Holding AG's (VTX:BANB) Price In Tune With Earnings

Bachem Holding AG's ( VTX:BANB ) price-to-earnings (or "P/E") ratio of 32x might make it look like a strong sell right...
Narrativ-Update • Sep 26

Building K Production Will Serve Peptide And Oligonucleotide Therapies

Bachem Holding's fair value has been revised downward, primarily reflecting slight declines in both its discount rate and future P/E ratio, with the consensus analyst price target decreasing from CHF77.88 to CHF74.70. What's in the News Maintained 2026 sales guidance of over CHF 1 billion and profitability above 30%.
Analyseartikel • Sep 18

Bachem Holding (VTX:BANB) Ticks All The Boxes When It Comes To Earnings Growth

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
Analyseartikel • Aug 16

Bachem Holding (VTX:BANB) Seems To Use Debt Quite Sensibly

SWX:BANB 1 Year Share Price vs Fair Value Explore Bachem Holding's Fair Values from the Community and select yours Some...
Analyseartikel • Jul 30

Bachem Holding's (VTX:BANB) Profits May Not Reveal Underlying Issues

The market for Bachem Holding AG's ( VTX:BANB ) stock was strong after it released a healthy earnings report last week...
Analyseartikel • Jul 25

Bachem Holding AG's (VTX:BANB) P/E Is Still On The Mark Following 28% Share Price Bounce

Bachem Holding AG ( VTX:BANB ) shares have continued their recent momentum with a 28% gain in the last month alone. But...
User avatar
Neues Narrativ • Mar 02

Building K And 24-Hour Operations Will Improve Efficiency

Capacity expansion and 24/7 operations enhance production, reduce costs, and bolster revenue growth in response to rising demand for peptides and oligonucleotides.

Gewinn- und Umsatzwachstumsprognosen

SWX:BANB - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CHF Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20281,346257-1043117
12/31/20271,153222-1662397
12/31/2026953181-2301597
12/31/2025695149-58272N/A
9/30/2025687141-95208N/A
6/30/2025678134-133144N/A
3/31/2025642127-136145N/A
12/31/2024605120-138146N/A
9/30/2024592117-96195N/A
6/30/2024578114-53244N/A
3/31/2024578113-36247N/A
12/31/2023577112-19250N/A
9/30/2023557105-40193N/A
6/30/202353799-62137N/A
3/31/2023534100-56115N/A
12/31/2022532101-5093N/A
9/30/202251599-4791N/A
6/30/202249998-4488N/A
3/31/2022501106-3293N/A
12/31/2021503115-1998N/A
9/30/20214841071107N/A
6/30/20214649821116N/A
3/31/20214338834116N/A
12/31/20204027846115N/A
9/30/20203797247103N/A
6/30/2020356674791N/A
3/31/2020335604178N/A
12/31/2019314543464N/A
9/30/201931052N/A60N/A
6/30/201930651N/A57N/A
3/31/201929449N/A41N/A
12/31/201828347N/A26N/A
9/30/201826845N/A24N/A
6/30/201825342N/A23N/A
3/31/201825742N/A30N/A
12/31/201726242N/A36N/A
9/30/201725241N/A36N/A
6/30/201724240N/A35N/A
3/31/201723941N/A38N/A
12/31/201623641N/A40N/A
9/30/201622939N/A46N/A
6/30/201622236N/A52N/A
3/31/201621634N/A57N/A
12/31/201520932N/A61N/A
9/30/201520331N/A59N/A
6/30/201519729N/A57N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: BANBDas prognostizierte Gewinnwachstum (15.8% pro Jahr) liegt über der Sparquote (0.6%).

Ertrag vs. Markt: BANBDie Erträge des Unternehmens (15.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Swiss (10.8% pro Jahr).

Hohe Wachstumserträge: BANBDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: BANBDie Einnahmen des Unternehmens (17% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Swiss (4.9% pro Jahr).

Hohe Wachstumseinnahmen: BANBDie Einnahmen des Unternehmens (17% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: BANBDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (14.1%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/06/25 01:27
Aktienkurs zum Tagesende2026/06/25 00:00
Gewinne2025/12/31
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Details des Analysemodells, das zur Erstellung dieses Berichts verwendet wurde, sind auf unserer GitHub-Seite verfügbar. Außerdem haben wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf YouTube.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Bachem Holding AG wird von 17 Analysten beobachtet. 7 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Charles PitmanBarclays
Estelle BétriseyBerenberg
Patrick LaagerBerenberg